Finally, track/trace action instead of talk

Wanted: pharma manufacturers to help get a track and trace prototype system off the ground.

That could be a sign planted on the lawn of Global Healthcare Exchange, a healthcare supply chain solutions provider. GHX is on its way to building such a prototype as phase 2 of its Track & Trace Project. Some version of the prototype may be in your future.

The company tells Pharmaceutical Commerce that the now complete phase 1 involved a requirements survey of pharma supply chain principals: manufacturers, distributors, and pharmacies. Findings include the gritty detail of master file data to be collected, data security and governance policies. GHX is currently working out the fundamentals of track-and-trace events, including order initiation, delivery receipt and payment, as well as the handling of snafus like missing data.

The phase 2 prototype will help uncover requirements for real-time data handling to validate the deliveries that comprise a pedigree. Transaction data security is another matter to be developed in phase 2, which is where GHX needs drugmaker participation.

It is hoped phase 2 will yield insights useful to regulators and policymakers, while also aiding the manufacturers and distributors now prepping for the California Board of Pharmacy's 2015 e-pedigree system deadline.

- here's the story

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)